This news is important to those who are diabetic and develop hypoglycemia as a complication of antidiabetic treatment.
Before moving to further information, If you learn something or if you find information provided in this video as help full, please motivate us by subscribing, liking and sharing this video.
Severe hypoglycemia occurs when a patient’s blood sugar levels fall to a level where he or she becomes confused or unconscious or suffers from other symptoms that require assistance from another person to treat.
Typically, severe hypoglycemia occurs in people with diabetes who are using insulin treatment.
Glucagon increases blood sugar levels in the body by stimulating the liver to release stored glucose into the bloodstream.
It has the opposite effect of insulin, which lowers blood sugar levels.
Until now, people suffering from a severe hypoglycemic episode had to be treated with a glucagon injection that first had to be mixed in a several-step process.
Injectable glucagon has been approved for use in the U.S. for several decades.
The U.S. Food and Drug Administration on 24 July 2019 approved Eli Lilly and Company’s, Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.
Baqsimi is approved to treat severe hypoglycemia in patients with diabetes ages four and older.
This new way to administer glucagon may simplify the process, which can be critical during an episode and simplify the treatment.
Baqsimi is a powder administered into the nose.
It will come in a single-use dispenser that can be given to someone suffering from a severe hypoglycemic episode.
Thank You for watching this video.
I hope this information will be helpful to you.
If you still not subscribed my channel, please subscribe for more such videos.
If you have any comments or questions, please write in comments section, I will definitely try to find out answer of your question.
Please share this video with your friends and do not forget to hit the like button.
Please visit my website: [ Ссылка ]
Check out my other videos:
SGLT2 inhibitors: Do you know about this new diabetes medications? [ Ссылка ]
New class of Oral diabetes drugs: DPP-4 Inhibitors / Gliptins: [ Ссылка ]
Side effects of steroids: [ Ссылка ]
6 MAJOR LONG TERM COMPLICATIONS OF DIABETES: [ Ссылка ]
Adalimumab (Humira/ Amgevita/ Imraldi/ Hyrimoz/ Hulio) -A magical drug for autoimmune diseases: [ Ссылка ]
Vyleesi (bremelanotide)- New Female Version of Viagra approved by FDA: [ Ссылка ]
FDA Warnings: Grapefruit Juice and Some Drugs Don't Mix: [ Ссылка ]
Orilissa / Elagolix: FDA approved New drug for endometriosis: [ Ссылка ]
FDA approved new drug SKYRIZI (risankizumab) for Plaque Psoriasis: an interleukin-23 inhibitor: [ Ссылка ]
Pharma, life science and medical news Jul 2019: [ Ссылка ]
#Pharmanews
#FDAnews
#medicalnews
